Koyfin Home > Directory > Health Care > Acceleron Pharma > Net Change in Cash

Acceleron Pharma Net Change in Cash Chart (XLRN)

Acceleron Pharma annual/quarterly Net Change in Cash from 2012 to 2020.
  • Acceleron Pharma Net Change in Cash for the quarter ending June 06, 2020 was $6m a 1.69% increase of 0m year over year
  • Acceleron Pharma Net Change in Cash for the last 12 months ending June 06, 2020 was $120m a 52.37% increase of 63m year over year
  • Acceleron Pharma Annual Net Change in Cash for 2019 was $94m a 52.61% increase of 49m from 2018
  • Acceleron Pharma Annual Net Change in Cash for 2018 was $44m a -78.93% decrease of -35m from 2017
  • Acceleron Pharma Annual Net Change in Cash for 2017 was $79m a 108.42% increase of 86m from 2016
Other Cash Flow Metrics:
  • Acceleron Pharma Cash Flow from Operations for the quarter ending December 12, 2018 was $-29m a 19.28% decrease of -6m year over year
  • Acceleron Pharma Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-41m a 62.43% decrease of -26m year over year
  • Acceleron Pharma Total Revenue for the quarter ending September 09, 2018 was $3m a -13.72% decrease of 0m year over year
View Chart On Koyfin

Quarterly XLRN Net Change in Cash Data

06/2020$6m
03/2020$40m
12/2019$68m
09/2019$6m
06/2019$-51m
03/2019$70m
12/2018$32m
09/2018$33m
06/2018$10m
03/2018$-30m

Annual XLRN Net Change in Cash Data

2019$94m
2018$44m
2017$79m
2016$-7m
2015$-149m
2014$63m
2013$74m
2012$-25m
2011$30m